维普期刊资源整合服务平台（V6.5）

50篇 您的检索式：作者名="ElkordE"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival显示文摘	Richard W. Griffiths Eyad Elkord David E. Gilham Vijay Ramani Noel Clarke Peter L. Stern Robert E. Hawkins	2007	Cancer Immunology, Immunotherapy2007，，：	2
2	T regulatory cells in cancer: recent advances and therapeutic potential显示文摘	Eyad Elkord Erik M Alcantar-Orozco Simon J Dovedi Dat Q Tran Robert E Hawkins David E Gilham	2010	Expert Opinion on Biological Therapy2010，，11：	1
3	Significance of CD44 and CD24 as cancer stem cell markers:an enduring ambiguity显示文摘	Jaggupilli A Elkord E		0，，：	1
4	Macrophage inhibitory cytokine-1:a review of its pleiotropic actions in cancer显示文摘	Khaled YS Elkord E Ammori BJ	2012	Cancer Biomark2012，11，5：	1
5	Tregulatory cells in cancer : recent advances and therapeuticpotential 显示文摘	Elkord E Alcantar-Orozco E M Dovedi S J	2010	Expert Opin Biol Ther2010，10，11：	1
6	Myeloid-derived suppressor cells in cancer: recent progress and prospects 显示文摘	Khaled YS Ammori B J Elkord E	2013	Immunol Cell Biol2013，91，8：	1
7	5T4 as a target for immunotherapY in renal cell carcinoma显示文摘	Elkord E Shablak A Stern P L	2009	Expert Rev Anticancer Ther2009，9，12：	1
8	Role of regulatory T cells in allergy: implications for therapeutic strategy 显示文摘	Elkord E	2006	Inflam Allergy Drug Targets2006，5，4：	1
9	Role of regulatory T cells in allergy:implications for therapeutic strategy显示文摘	Elkord E	2006	Inflamm Allergy Drug Targets2006，5，4：	1
10	Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity显示文摘	Appalaraju Jaggupilli Eyad Elkord Michael H. Kershaw	2012	Clinical and Developmental Immunology2012，，：	1
11	Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma 显示文摘	Thistlethwaite FC Elkord E Griffiths RW	2008	Cancer Immunol Immunother2008，57，5：	1
12	T regula- tory cells in cancer: recent advances and therapeutic potential 显示文摘	Elkord E Alcantar-Orozco EM Dovedi SJ	2010	Expert Opin Biol Ther2010，10，：	1
13	Myeloid - derived suppressor cells in cancer:recent progress and prospects 显示文摘	Khaled YS Ammori B J ElkordE	2013	Immunol Cell Biol2013，91，8：	1
14	T regulatory cells in cancer: Recent advances and therapeutic potential 显示文摘	Elkord E Alcantar-Orozco EM Dovedi SJ	2010	Expert Opin Biol Ther2010，10，11：	1
15	Adoptive transfer of T(reg) depleted autologous T ceils in advanced renal cell carcinoma 显示文摘	Thistlethwaite FC Elkord E Griffiths RW	2008	Cancer Immunol Immunother2008，57，5：	1
16	Expanded subpopula- tion of Foxp3T regulatory cells in renal cell carcinoma co-express Helios,indicating they could be derived from natural but not in- duced Tregs显示文摘	Elkord E Sharma S Burt DJ Hawkins RE	2011	Clin Immunol2011，140，：	1
17	Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients显示文摘	Khaled YS Ammori BJ Elkord E	2014	J Immunol Res2014，2014，：	1
18	Significance of CD44 and CD24 as cancer stem cell markers:an enduring ambiguity显示文摘	Jaggupilli A Elkord E	2012	Clin Dev Immunol2012，，70：	1
19	Modulation of lymphocyte regulation for cancer therapy:a phaseⅡtrial of tremelimumab in advanced gastric and esophageal adenocarcinoma显示文摘	Ralph C Elkord E Burt DJ	2010	Clin Cancer Res2010，16，5：	1
20	Modulation of lymphocyte regulation for cancer therapy : a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma 显示文摘	Ralph C Elkord E	2010	Clin Cancer Res2010，16，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示